Skin / Anti-Aging Research Program
This is an educational summary of research areas relevant to this goal. SmartPeptide does not prescribe peptides or recommend dosages. Always consult a licensed healthcare provider.
Educational only — not medical advice. SmartPeptide does not prescribe, diagnose, or treat. Always consult a licensed healthcare provider before using any peptide, supplement, medication, or protocol.
Evidence landscape
Aggregated across all 3 peptides in this categoryGoal
Educational overview for skin / anti-aging research program.
Research overview
Research overview compiled from publicly available abstracts and reviews. Quality of evidence varies — some peptides have only preclinical data.
All 3 peptides in this category
Ranked by evidence quality: strongest human evidence first, preclinical and anecdotal last.
- GHK-CuLimited human evidence
Copper tripeptide studied in dermatology for skin remodeling and wound contexts. Topical formulations are widely used in cosmetics.
- Argireline (Acetyl Hexapeptide-8)Limited human evidence
Synthetic hexapeptide (Glu-Glu-Met-Gln-Arg-Arg) marketed as a topical 'botox alternative.' Theoretically interferes with SNARE complex formation, reducing neurotransmitter release at neuromuscular junctions. Topical formulations are widely sold in cosmetics. Effect size is modest at best in published trials.
- Melanotan IILimited human evidence
Synthetic analog of α-melanocyte-stimulating hormone (α-MSH). Binds melanocortin receptors (notably MC1R for tanning and MC4R for sexual function). Originally researched for therapeutic skin pigmentation; abandoned in clinical development. Sold heavily as a grey-market 'tanning peptide.' Significant safety concerns — Class A action by some regulators.
Lifestyle suggestions
Foundational lifestyle factors (sleep, nutrition, training, stress) often outperform any single intervention in published research.
Lifestyle factors (sleep, nutrition, training, stress) are foundational. SmartPeptide does not provide exact dosing instructions for any peptide.
Questions for your clinician
- What is the strongest human evidence for the peptides I'm considering?
- Which option here is FDA-approved vs. research-only?
- What baseline + monitoring labs would you recommend for my goal?
- What signs of harm or adverse reactions should I watch for?
- How will we measure benefit objectively?
- What's the exit criteria if it's not working?